文章摘要
吉建,张虹,吕艳艳.某医院 2015—2017年非甾体类抗炎药使用情况分析[J].安徽医药,2020,24(1):201-205.
某医院 2015—2017年非甾体类抗炎药使用情况分析
Analysis on the use of oral non?steroidal anti?inflammatory drugs in a hospital from 2015 to 2017
  
DOI:10.3969/j.issn.1009?6469.2020.01.051
中文关键词: 消炎药,非甾类  药物利用评审  环氧化酶 2  药物处方  处方不当  艾瑞昔布  塞来昔布  美洛昔康  用药频度  限定日费用
英文关键词: Anti?inflammatory agents,non?steroidal  Drug utilization review  Cyclooxygenase 2  Drug prescriptions  Inappropriate prescribing  Imrecoxib  Celecoxib  Meloxicam  Defined daily dose system  Defined daily cost
基金项目:河南省科技攻关项目( 162102310367);河南省中医药科学研究专项课题( 2017ZY2089);河南省中医药拔尖人才项目[豫中医科教( 2018)35号]
作者单位E-mail
吉建 河南省洛阳正骨医院河南省骨科医院河南洛阳 471002  
张虹 河南省洛阳正骨医院河南省骨科医院河南洛阳 471002 lyzgzh2008@163.com 
吕艳艳 河南省洛阳正骨医院河南省骨科医院河南洛阳 471002  
摘要点击次数: 2344
全文下载次数: 667
中文摘要:
      目的分析某医院门诊非甾体抗炎药( NSAIDs)的使用情况,为临床合理用药提供参考。方法收集河南省洛阳正骨医院 2015—2017年口服 NSAIDs的相关用药信息,对药物种类、销售金额、用药频度( DDDs)、限定日费用( DDC)和排序比进行统计分析,并抽取 100张/月 NSAIDs处方进行用药合理性分析。结果 NSAIDs总销售金额连续 3年呈递增趋势,选择性新型的环氧合酶 2(COX?2)抑制剂中艾瑞昔布片 3年均稳居销售金额排名的第 1位,塞来昔布胶囊 3年均稳居 DDDs排名的第 1位,艾瑞昔布片的 DDC最大,美洛昔康胶囊的 DDC最小;非选择性 NSAIDs中醋氯芬酸缓释片连续 3年稳居销售金额和 DDDs排名的第 1位,氨酚双氢可待因片的 DDC最大,双氯芬酸钠缓释胶囊的 DDC最小,总体同步性好。 NSAIDs处方不合理用药类型主要为用法与用量不适宜、联合用药不适宜、重复给药。结论该院 NSAIDs用药结构日趋合理,选择性 COX?2抑制剂的使用频率不断增大,不合理用药情况仍存在,临床应用应根据病人情况选择合适的药物,提高用药安全水平。
英文摘要:
      Objective To investigate the utilization of oral non?steroidal anti?inflammatory drugs(NSAIDs)in our hospital and pro? vide reference for clinical rational drug use.Methods The relevant medication information of oral NSAIDs of Henan Luoyang Or?thopedic ? Traumatological Hospital from 2015—2017 was collected,and the drug varieties,sales amount,defined daily doses(DDDs)average daily cost(DDC),and sorting ratio were analyzed statistically,and 100 prescriptions with NSAIDs were extracted fordrugrat,ionality analysis monthly.Results Consumption sum of oral NSAIDs showed a rising trend for three consecutive years.Consumption sum of imrecoxib tablets in the new cyclooxygenase?2(COX?2)selective inhibitors ranked the first for three consecu? tive years,DDDs of celecoxib capsules for the COX?2 selective inhibitors ranked the first for three consecutive years,DDC of imre? coxib tablets ranked the first,while DDC of meloxicam capsules ranked the last.Consumption sum and DDDs of aceclofenac sus?tained?release tablets for the non?selective NSAIDs ranked the first for three consecutive years,DDC of aminophenol dihydroco? deine tablets ranked the first,while DDC of diclofenac sodium sustained release capsules ranked the last.The main irrational drugapplication included improper dosage,improper usage combination and drug repetition.Conclusion The medication structure of NSAIDs has become more and more rationalized in our hospital,while the market share of COX?2 selective inhibitors is continuous?ly expending.The irrational use of drugs still exists.In the application of NSAIDs,the appropriate drugs should be selected accord? ing to the patient’s condition to improve the safety level of medication.
查看全文   查看/发表评论  下载PDF阅读器
关闭

分享按钮